China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co., often referred to as China TCM, is a prominent player in the traditional Chinese medicine industry, headquartered in China (CN). Established in 2001, the company has made significant strides in promoting the benefits of traditional herbal remedies and therapies across major operational regions, including Asia and beyond. Specialising in the research, development, and distribution of traditional Chinese medicinal products, China TCM offers a unique range of herbal formulations and health supplements that are rooted in centuries-old practices. The company is recognised for its commitment to quality and innovation, ensuring that its products meet rigorous health standards. With a strong market position, China TCM has achieved notable milestones, including strategic partnerships and a growing international presence, solidifying its reputation as a leader in the traditional medicine sector.
DitchCarbon Score
How does China Traditional Chinese Medicine Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Traditional Chinese Medicine Holdings Co's score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Traditional Chinese Medicine Holdings Co's reported carbon emissions
In 2022, China Traditional Chinese Medicine Holdings Co. reported total carbon emissions of approximately 377,850,700 kg CO2e. This figure includes 122,799,100 kg CO2e from Scope 1 emissions and 255,051,600 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Comparatively, in 2021, the total emissions were about 292,492,300 kg CO2e, with Scope 1 contributing 124,850,700 kg CO2e and Scope 2 at 167,641,600 kg CO2e. In 2020, emissions were approximately 306,697,800 kg CO2e, comprising 105,687,600 kg CO2e from Scope 1 and 201,010,200 kg CO2e from Scope 2. The trend indicates a significant increase in emissions from 2020 to 2022. Despite these figures, China Traditional Chinese Medicine Holdings Co. has not set any specific reduction targets or climate pledges, nor have they reported any initiatives under the Science Based Targets initiative (SBTi). The absence of reduction commitments suggests a need for enhanced climate action within the organisation. The emissions data is sourced directly from China Traditional Chinese Medicine Holdings Co. Limited, with no cascading from a parent or related organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 92,186,400 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 157,421,300 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Traditional Chinese Medicine Holdings Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
